Compare Multistrada Arah Sarana Tbk. (MASA) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Multistrada Arah Sarana Tbk. vs Merck Tbk. — how do they compare? Multistrada Arah Sarana Tbk. trades at Rp6,200 (market cap 56.93T), while Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume). The key difference: Multistrada Arah Sarana Tbk. is far larger — about 32.3× Merck Tbk.'s market cap. Which is the better fit depends on your goals.
| MASA | MERK | |
|---|---|---|
Market Cap | 56.93T | 1.76T |
Volume | — | 63K |
Lot | — | 630 |
Turnover | — | 243.97M |
Average Price | — | 3,872.46 |
Value | — | 243.97M |
Indicative Equilibrium Price | — | 3,900 |
Indicative Equilibrium Volume | — | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Multistrada Arah Sarana Tbk.
Multistrada Arah Sarana, PT (the company) was established under its original name of PT Oroban Perkasa on Jun 20th 1988. The company starts commercial operation in 1995. The articles of association have been amended several times, most recently on January 31, 2005, concerning public offering.
Read more on MASA →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
